BEAT Heartbeam, Inc.
$0.40▼ -2.15%
Healthcare
Other
After hours
$0.40▼ -0.10%
Oct 27, 4:52 PM ET
Volume 1.21M
Avg Volume (10D) 847.1K
Key Metrics & Fundamentals
Market Cap
$22.56M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.36 - 4.00
% vs 50 MA
-8.77%
% vs 200 MA
-55.16%
RSI-14
44.9
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.89
Free Cash Flow
-$3.59M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$5.04M
COGS
–
Operating Exp
$5.09M
Operating Income
-$5.09M
EBIT
-$5.09M
Pretax Income
-$5.04M
Net Income
-$5.04M
EPS (Diluted)
-0.10
Price & Volume History
Loading chart…
Recent News
HeartBeam’s Heart Attack Assessment Technology Accepted into FDA’s Total Product Life Cycle Advisory Program (TAP)
Business Wire · Oct 26, 2026 8:31 AM ET
HEADSTART-ACS Completes Enrollment Ahead of Schedule, the Largest Heart Attack Detection Study to Date Using HeartBeam Technology
Business Wire · Oct 21, 2026 8:31 AM ET
HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk Patients
Business Wire · Oct 15, 2026 8:31 AM ET
HeartBeam stock soars on FDA breakthrough designation
Investing.com · Oct 5, 2026 11:05 AM ET
BC-Most Active Stocks
Associated Press · Oct 5, 2026 10:30 AM ET
HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment
InvestorsHub · Oct 5, 2026 10:20 AM ET
HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment
Business Wire · Oct 5, 2026 8:31 AM ET
HeartBeam, Inc. Letter to Shareholders
Business Wire · Sep 21, 2026 8:31 AM ET
HeartBeam, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 14, 2026 8:30 AM ET
HeartBeam Inc (BEAT) (Q2 2026) Earnings Call Highlights: FDA Submission Advances and Commercial ...
GuruFocus.com · Aug 14, 2026 1:02 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See BEAT's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.